A citation-based method for searching scientific literature

Christine Garcia, Jacqueline Wendt, Liisa Lyon, Jennifer Jones, Ramey D Littell, Mary Anne Armstrong, Tina Raine-Bennett, C Bethan Powell. Gynecol Oncol 2014
Times Cited: 58



Noah D Kauff, Susan M Domchek, Tara M Friebel, Mark E Robson, Johanna Lee, Judy E Garber, Claudine Isaacs, D Gareth Evans, Henry Lynch, Rosalind A Eeles, Susan L Neuhausen, Mary B Daly, Ellen Matloff, Joanne L Blum, Paul Sabbatini, Richard R Barakat, Clifford Hudis, Larry Norton, Kenneth Offit, Timothy R Rebbeck. J Clin Oncol 2008
Times Cited: 348




List of shared articles



Times cited

Ovarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease Prevention.
Katherine Karakasis, Julia V Burnier, Valerie Bowering, Amit M Oza, Stephanie Lheureux. Front Oncol 2016
12

Impact of Genetic Testing on Risk-Management Behavior of Black Breast Cancer Survivors: A Longitudinal, Observational Study.
Claire C Conley, Monica L Kasting, Bianca M Augusto, Jennifer D Garcia, Deborah Cragun, Brian D Gonzalez, Jongphil Kim, Kimlin Tam Ashing, Cheryl L Knott, Chanita Hughes-Halbert,[...]. Ann Surg Oncol 2020
1

Cancer Risk-Reducing Opportunities in Gynecologic Surgery.
Carolyn Piszczek, Jun Ma, Claire H Gould, Paul Tseng. J Minim Invasive Gynecol 2018
2


The effect of personal medical history and family history of cancer on the uptake of risk-reducing salpingo-oophorectomy.
Jessica E van der Aa, Jacob P Hoogendam, Els S F Butter, Margreet G E M Ausems, René H M Verheijen, Ronald P Zweemer. Fam Cancer 2015
7

A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer.
Anthony Eccleston, Anthony Bentley, Matthew Dyer, Ann Strydom, Wim Vereecken, Angela George, Nazneen Rahman. Value Health 2017
30

Attitudes towards risk-reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study.
F Gaba, O Blyuss, D Chandrasekaran, M Osman, S Goyal, C Gan, L Izatt, V Tripathi, I Esteban, L McNicol,[...]. BJOG 2021
1

A comprehensive approach to the identification and management of the BRCA patient.
Christine Garcia, C Bethan Powell. Obstet Gynecol Surv 2015
3


Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers.
Xinglei Chai, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. Breast Cancer Res Treat 2014
34

Population Screening for Inherited Predisposition to Breast and Ovarian Cancer.
Ranjit Manchanda, Sari Lieberman, Faiza Gaba, Amnon Lahad, Ephrat Levy-Lahad. Annu Rev Genomics Hum Genet 2020
10

Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction.
B A M Heemskerk-Gerritsen, C Seynaeve, C J van Asperen, M G E M Ausems, J M Collée, H C van Doorn, E B Gomez Garcia, C M Kets, F E van Leeuwen, H E J Meijers-Heijboer,[...]. J Natl Cancer Inst 2015
113

Genetics of gynaecological cancers.
Panayiotis Constantinou, Marc Tischkowitz. Best Pract Res Clin Obstet Gynaecol 2017
9

Uptake and efficacy of bilateral risk reducing surgery in unaffected female BRCA1 and BRCA2 carriers.
Ruta Marcinkute, Emma Roisin Woodward, Ashu Gandhi, Sacha Howell, Emma J Crosbie, Julie Wissely, James Harvey, Lindsay Highton, John Murphy, Cathrine Holland,[...]. J Med Genet 2021
0